Compare Agilent Technologies Inc (A) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Okta, Inc. — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Okta, Inc. trades at $151.85 (market cap $26.20B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Agilent Technologies Inc pays a 0.69% dividend while Okta, Inc. pays none. Which is the better fit depends on your goals.
| A | OKTA | |
|---|---|---|
Market Cap | $42.00B | $26.20B |
Sector | Health | Technology |
52-Week High | $157.20 | $154.62 |
52-Week Low | $110.24 | $62.93 |
Enterprise Value | $43.55B | $24.03B |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
OKTA trades at $148.32, up 3.35% today, near its recent high of $157.00. The stock shows bullish momentum with consistent earnings beats, including Q1 2026 EPS of $0.91 versus $0.853 expected. Revenue growth is robust, rising from $1.3B in 2022 to $2.6B in 2025, with net income turning positive at $28M. Technical indicators signal bullish trends, while analyst consensus is strongly positive with 72.55% buy ratings.
Outlook is favorable due to strong cybersecurity demand and AI-driven product launches, but risks include high valuation (P/E of 107.48) and competition. Upside potential exists if earnings growth continues, with a consensus price target of $127.96 suggesting caution relative to current price. Investors should monitor Q2 2026 results on August 26, 2026, for confirmation of profitability trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
